Founding Director, CASMI and New Medicine Partners
Richard is Director of the Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), a major UK initiative aimed at transforming the R&D and regulatory processes in life sciences to bring advances more rapidly and affordably to patients. He was recently appointed as chair of the Precision Medicine Catapult, forging a national strategy in this rapidly developing field. He is also chairman of the South London Academic Health Science Network, accelerating innovation in this region of the NHS, and of the corresponding Genomic Medicine Centre. He also chairs Image Analysis, a UK company using MRI to quantify the impact of therapy on disease. He is a board member of Celgene, a major USbased bio-therapeutics company and of iCo Therapeutics, a Canadian bioscience company. His 25-year business career in healthcare has spanned biopharmaceuticals, diagnostics and medical informatics – both in the USA and Europe. Most recently he was Director General of the Association of the British Pharmaceutical Industry, Board member of EFPIA (the European industry association) and Council member of IFPMA (the international equivalent). As a co-founder of Life Sciences UK, member of the NHS Stakeholder Forum, vice-chair of the UK Clinical Trials Collaboration and in many other roles, he has advised successive UK governments on healthcare issues, especially those relating to developing, valuing and using new healthcare technologies.